← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Versiti Blood Health, Inc.
Milwaukee, WI
$23,517,784
Total funding
39
Grants
Funding over time
peak $23.2M · FY2020–25$25M$18.8M$12.5M$6.3M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,213,751 · 35
DOD$5,304,033 · 4
By mechanism
R01$11,456,674 · 17
—$5,304,033 · 4
P01$4,767,215 · 11
S10$679,925 · 1
R35$412,500 · 1
K01$316,440 · 2
Investigators at Versiti Blood Health, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Molecular Mechanisms of Immune Thrombocytopenia in Transfusion Medicine$2,553,290
P01 · FY2025 · HL
Molecular and Clinical Glycobiology of the Bone Marrow Environment$2,459,915
P01 · FY2025 · HL
MINIMALLY INVASIVE DEVICE AND BIOABSORBABLE HEMOSTATIC POWDER FOR MANAGING NONCOMPRESSIBLE TORSO HEMORRHAGE$2,000,000
· FY2021 · Defense Health Agency
CONTROLLING THROMBOEMBOLISM AFTER POLYTRAUMA WITH AN RNA THERAPY AGAINST EXCESS FIBRINOGEN$1,993,215
· FY2024 · Defense Health Agency
Pulmonary arteriole occlusion by platelet-neutrophil micro-emboli in Acute Chest Syndrome$1,505,882
R01 · FY2025 · HL
ENHANCING TRANSFUSABLE PLATELETS FOR HEMORRHAGE CONTROL USING LIPOSOMAL TRANSFECTION$1,160,943
· FY2020 · Defense Health Agency
Structural Transition of Cellular Integrins and Applications Thereof$797,844
R01 · FY2025 · HL
CD39-carrying extracellular vesicles regulate pulmonary thrombosis in Sickle Cell Disease$774,566
R01 · FY2025 · HL
Characterization of an isoform specific anticoagulant function of TFPI-alpha$739,302
R01 · FY2025 · HL
Endothelial Rap1 in the control of heart function$738,805
R01 · FY2025 · HL
Molecular Basis of the Humoral Immune Response in Heparin-Induced Thrombocytopenia$727,901
R01 · FY2025 · HL
Non-conventional signaling by α5 integrin in blood and endothelial cells$718,854
R01 · FY2025 · HL
Understanding and Controlling the Contribution of Fibrinolysis to Bleeding Using a Long-Acting Antifibrinolytic RNA Therapy$718,283
R01 · FY2025 · HL
The Immunobiology of Heparin-Induced Thrombocytopenia$711,500
P01 · FY2025 · HL
High parameter fluorescence activated cell sorter$679,925
S10 · FY2025 · OD
B-cell response and thrombotic complications in COVID-19$659,871
R01 · FY2025 · HL
The Immunobiology of Vaccine-induced Immune Thrombotic Thrombocytopenia$633,990
P01 · FY2025 · HL
Project 1: Megakaryocytes as Organizers of the Hematopoietic Environment$620,183
P01 · FY2025 · HL
The Immunobiology of Fetal/Neonatal Alloimmune Thrombocytopenia$618,750
P01 · FY2025 · HL
Membrane-cytoskeleton interactions in megakaryocytes and platelets$604,301
R01 · FY2025 · HL